Latest News
Welcome New Staff, Faculty, Postdocs & Postgrads (November 2024)
- November 05, 2024
Yale faculty, trainees, postdocs, and students will present research at the upcoming American Heart Association Scientific Sessions in Chicago later this month.
- November 01, 2024Source: LiveScience.com
Scientists reprogrammed a woman's fat cells to become insulin-making beta cells, reversing her type 1 diabetes.
- October 16, 2024
The Department of Internal Medicine is pleased to welcome the following new staff, faculty, postgraduate fellows, postgraduate associates, and postdoctoral associates who joined the team in September 2024.
- October 07, 2024
Peter Tebben, MD, an adult and pediatric endocrinologist, has joined Yale School of Medicine (YSM) as the new director of the Yale Bone Center.
- September 24, 2024Source: Newswise
The 2025 BPS Award in the Biophysics of Health & Disease is given to Elizabeth A. Jonas of Yale School of Medicine for her groundbreaking research in biophysics and neuroscience and her continuous service to the Biophysical Society's Bioenergetics, Mitochondria, and Metabolism Subgroup.
- September 24, 2024Source: Biophysical Society
The Biophysical Society is pleased to announce that Elizabeth A. Jonas, MD, of Yale University School of Medicine, has been named the recipient of the 2025 BPS Award in the Biophysics of Health and Disease. Jonas will be honored at the Society’s 69th Annual Meeting, being held in Los Angeles, California from February 15-19, 2025.
- September 19, 2024Source: Yale Insights
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology) at Yale School of Medicine, discusses the range of diseases treated by novel weight-loss drugs such as Ozempic, Mounjaro, and Wegovy.
- September 18, 2024Source: MSN
A new study by researchers at Yale School of Medicine (YSM), published Aug. 27 in the journal Cell Metabolism, finds that people with MASLD burn fat in their livers at the same rate as people without the disease. The study, whose senior author is Gerald Shulman, MD, Ph.D., George R. Cowgill Professor of Medicine (Endocrinology) and professor of cellular and molecular physiology at YSM, appears to settle this question, which has been in dispute in the field.
- September 17, 2024
A new study shows that a glucose-related hormone revs up liver metabolism, which has implications for treating fatty liver disease with a new class of weight loss drugs, and shows how the disease affects liver fat burning.